The Effect of Exercise Training on Walking Ability and Health-Related Quality of Life in Patients with Moderate to Severe Peripheral Arterial Disease

mately 70% of patients with TAO develop critical limbthreatening ischemia (CLTI) of Fontaine Class III or higher during progression, and approximately 10% of these patients undergo major amputation surgery. 2 Further, approximately 20% of patients require minor ampu-T hromboangiitis obliterans (TAO; Buerger's disease) is more common among men in their 30s and 40s, and shows a strong causal association with smoking. However, the pathogenesis of TAO remains unknown, and it is categorized as an incurable disease. 1 Approxi-

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The Effect of Exercise Training on Walking Ability and Health-Related Quality of Life in Patients with Moderate to Severe Peripheral Arterial Disease

Cited by 2 publications

References 12 publications

Establishment of optimal exercise therapy using near-infrared spectroscopy monitoring of tissue muscle oxygenation after therapeutic angiogenesis for patients with critical limb ischemia: A multicenter, randomized, controlled trial

Establishment of optimal exercise therapy using near-infrared spectroscopy monitoring of tissue muscle oxygenation after therapeutic angiogenesis for patients with critical limb ischemia: A multicenter, randomized, controlled trial

A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans

Contact Info

Product

Resources

About